Evidence that both ET(A) and ET(B) receptor subtypes are involved in the in vivo aldosterone secretagogue effect of endothelin-1 in rats

Research in Experimental Medicine

Volumn 196, Issue 3, 1996, Pages 145-152

  Mazzocchi, G ^a   Rebuffat, P ^a   Gottardo, G ^a   Meneghelli, V ^a   Nussdorfer, G G ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Adrenal cortex; Aldosterone; Blood pressure; Endothelin 1; Rat

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; RECEPTOR SUBTYPE; ANGIOTENSIN II; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN RECEPTOR; OLIGOPEPTIDE; PIPERIDINE DERIVATIVE;

ADRENAL CORTEX; ALDOSTERONE RELEASE; ANIMAL EXPERIMENT; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; ZONA GLOMERULOSA; ANIMAL; BLOOD; BLOOD PRESSURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; PHYSIOLOGY; SECRETION; WISTAR RAT;

ADRENAL CORTEX; ALDOSTERONE; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; MALE; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PIPERIDINES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN;

EID: 0029760645     PISSN: 03009130     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004330050021     Document Type: Article

References (34)

1. Rubanyi GM, Polokoff MA (1994) Endothelins: molecular biology, biochemistry, pharmacology, physiology and pathophysiology. Pharmacol Rev 46:325-415
2. Hinson JP, Vinson GP, Kapas S, Teja R (1991) The role of endothelin in the control of adrenocortical function: stimulation of endothelin release by ACTH and the effects of endothelin-1 and endothelin-3 on steroidogenesis in rat and human adrenocortical cells. J Endocrinol 128:275-280
3. Mazzocchi G, Malendowicz LK, Nussdorfer GG (1990) Endothelin-1 acutely stimulates the secretory activity of rat zona glomerulosa cells. Peptides 11:763-765
4. Mazzocchi G, Rebuffat P, Meneghelli V, Malendowicz LK, Kasprzak A, Nussdorfer GG (1990) Effects of prolonged infusion with endothelin-1 on the function and morphology of rat adrenal cortex. Peptides 11:767-772
5. Pecci A, Gomez-Sanchez CE, De Bedners MEO, Lantos CP, Cozza EN (1993) In vivo stimulation of aldosterone biosynthesis by endothelin: loci of action and effects of doses and infusion rate. J Steroid Biochem Mol Biol 45:555-561
6. Pecci A, Cozza EN, Devlin M, Gomez-Sanchez CE, Gomez-Sanchez EP (1994) Endothelin-1 stimulation of aldosterone and zona glomerulosa ouabain-sensitive sodium/potassium-ATPase. J Steroid Biochem Mol Biol 50:49-53
7. Zeng ZP, Naruse M, Guan BJ, Naruse K, Sun ML, Zang MF, Demura H, Shi YF (1992) Endothelin stimulates aldosterone secretion in vitro from normal adrenocortical tissue, but not adenoma tissue, in primary aldosteronism. J Clin Endocrinol Metab 74:874-878
8. 125I]endothelin-1 in humans, pigs and rats: functional relevance in humans. J Cardiovasc Pharmacol 13 (Suppl 5):S177-S180
9. Kohzuki M, Johnston CI, Abe K, Chai SY, Casley D, Yasujima M, Yoshinaga K, Mendelsohn FAO (1991) In vitro autoradiographic endothelin-1 binding sites and sarafotoxin S6B binding sites in rat tissues. Clin Exp Pharmacol Physiol 18:509-515
10. Koseki C, Imai M, Hirata Y, Yanagisawa M, Masaki T (1989) Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide? Am J Physiol 256:R858-R866
11. 125I-big endothelin-1 in rat tissues: autoradiographic localization and receptor binding. Histochemistry 95:621-628
12. Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S (1991) Cloning and expression of cDNA encoding an endothelin receptor. Nature 348:730-732
13. Belloni AS, Rossi GP, Andreis PG, Neri G, Albertin G, Pessina AC, Nussdorfer GG (1996) Endothelin adrenocortical secretagogue effect is mediated by the B receptor in rats. Hypertension 27:1153-1159
14. Rossi GP, Albertin G, Belloni AS, Zanin L, Biasolo MA, Prayer-Galetti T, Bader M, Nussdorfer GG, Palù G, Pessina AC (1994) Gene expression, localization and characterization of endothelin A and B receptors in the human adrenal cortex. J Clin Invest 94:1226-1234
15. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T (1991) Cloning of cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348:732-735
16. Belloni AS, Rossi GP, Zanin L, Prayer-Galetti T, Pessina AC, Nussdorfer GG (1994) In vitro autoradiographic demonstration of endothelin-1 binding sites in the human adrenal cortex. Biomed Res 15:95-99
17. A receptor. Life Sci 50:247-256
18. Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, Fukami T, Ozaki S, Nagase T, Nishikibe M, Yano M (1994) Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci USA 91:4892-4896
19. Neri G, Malendowicz LK, Andreis PG, Nussdorfer GG (1993) Thyrotropin-releasing hormone inhibits glucocorticoid secretion of rat adrenal cortex: in vivo and in vitro studies. Endocrinology 133:511-514
20. Quinn SJ, Williams GH (1992) Regulation of aldosterone secretion. In: James VTH (ed) The adrenal gland. Raven Press, New York, pp 159-189
21. Naruse M, Naruse K, Demura H (1994) Recent advances in endothelin research on cardiovascular and endocrine systems. Endocrine J 41:491-507
22. Takuwa Y (1993) Endothelin in vascular and endocrine systems: biological activities and its mechanisms of action. Endocrine J 40:489-506
23. Vinson GP, Hinson JP, Toth IE (1994) The neuroendocrinology of the adrenal cortex. J Neuroendocrinol 6:235-246
24. Boarder MR, Marriott DB (1991) Endothelin-1 stimulation of noradrenaline and adrenaline release from adrenal chromaffin cells. Biochem Pharmacol 41:521-526
25. Goetz KL, Wang BC, Madwed JB, Zhu JL, Leadley J Jr (1988) Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 255:R1064-R1068
26. Yamaguchi N (1993) Inhibition by nifedipine of endothelin-induced adrenal catecholamine secretion in anesthetized dogs. Can J Physiol Pharmacol 71:301-305
27. Wilkes LC, Boarder MR (1991) Characterization of the endothelin binding site on ovine adrenomedullary chromaffin cells: comparison with vascular smooth muscle cells. Evidence for receptor heterogeneity. J Pharmacol Exp Ther 256:628-633
28. Vinson GP, Hinson JP (1992) Blood flow and hormone secretion in the adrenal gland. In: James VHT (ed) The adrenal gland. Raven Press, New York, pp 71-86
29. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by endothelial cells. Nature 332:411-415
30. A receptor in the maintenance of deoxycorticosterone acetate-salt-induced hypertension. Br J Pharmacol 114:925-930
31. Li JS, Schiffrin EL (1995) Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist. Hypertension 25:495-500
32. Bazil MK, Lappe RW, Webb RL (1992) Hemodynamic effects of an endothelin (ET) receptor antagonist in three rat models of hypertension. J Hypertension 10 (Suppl 4):S49
33. A receptor antagonist, in spontaneously hypertensive rats treated with DOCA-salt. Eur J Pharmacol 259:339-342
34. Bazil MK, Lappe RW, Webb RL (1992) Hemodynamic effects of an endothelin (ET) receptor antagonist in three rat models of hypertension. J Hypertension 10 (Suppl 4): S49